Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDC42 pseudogene 1 (CDC42P1) is a pseudogene in humans and does not encode a functional protein product. As a pseudogene, it shares sequence similarity with the active *CDC42* gene but lacks the capability to produce an active enzyme or receptor. Pseudogenes like CDC42P1 are generally considered genetically inactive, and there is no experimental evidence linking CDC42P1 to any biological function, disease role, or drug interactions[5]. *CDC42P1* is distinct from the functional *CDC42* gene, which encodes a small GTPase involved in key cellular processes, signaling, and cancer[1][3][4]. However, *CDC42P1* itself does not possess these functional properties and is not a therapeutic or druggable target[5]. No disease associations, biomarkers, or pharmacological interactions have been reported for CDC42P1[5]. This is consistent with standard conventions for molecular target annotation, where pseudogenes are classified as "Other" and not generally considered druggable or functionally relevant in the context of target-based drug discovery or therapeutics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDC42 pseudogene 1 (CDC42P1).